Taken together, Scott-Levin products can give clients the most accurate possible picture of total pharmaceutical promotion.
It has more than 600 products in nexium drug development.
The launch of Nexium in six markets this year - Sweden, Britain, Denmark, Norway, Germany and Ireland - and in the US in 2001 alongside other drugs, will see AstraZeneca spend an additional $320m (pounds 214m) this year on marketing, including the recruitment of 1,300 staff in the US. Laheij at University Medical Center nexium drug st. The FDA-approved "label" for Lexiva (the official prescribing information for physicians) nexium drug urges caution in using the drug together with proton-pump inhibitors, because experience with other drugs suggested that the blood level of the antiviral might be decreased, making it less effective (no test with Lexiva and Nexium had been done). Pharmaceutical sales representatives who detail Nexium to physicians usually compare the new product to nexium drug the older Prilosec, reports Scott-Levin's Personal Selling Audit/Hospital Personal Selling Audit, which measures selling activity to doctors.

Its chief executive, Tom McKillop, has said nexium drug the drug will confirm the group's global leadership in the gastro-intestinal market. The deja vu nexium drug aspect of Nexium doesn't trouble the Food and Drug Administration. Analysts were yesterday speculating that the pricing of the drug will be the focus of the FTC's investigation. The manufacturer makes a nexium drug lot more money when you use Nexium.

Nexium drug initial data suggests Astra-Zeneca's market share is holding up and prescription numbers for the new drug are promising, but it will take another couple of months before any significant conclusions can be drawn. Both drugs come in delayed-release form, so AstraZeneca has not nexium drug introduced a new format. Losec comes off patent around the world next year. Its high-speed data business in the US is likely to be a main driver of growth, but analysts disagree over whether results will show a small profit. The valuation nexium drug is hard to stomach. Glaxo is seeking FDA permission to change it, in view of the new data. AstraZeneca started this false promotional campaign as the patent for Prilosec was set to expire in 2001.